Why is there a class action lawsuit against Insulet Corporation (NASDAQ: PODD)?

The Insulet securities class action lawsuit alleges that the company made false and misleading statements regarding its manufacturing controls and procedures. The complaint claims these deficiencies created a heightened, foreseeable risk that its products would violate safety regulations or pose injury risks. The issues came to light following voluntary Medical Device Corrections for specific lots of Omnipod® products in March and May 2026, which triggered sharp declines in the PODD stock price.

What caused the Insulet (PODD) stock drops in March and May 2026?

Insulet’s stock suffered two major drops tied to manufacturing issues: • March 13, 2026: The stock fell 6.88% ($16.23/share) to close at $219.84 after the company announced a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods. • May 27, 2026: The stock fell an additional 5.07% ($7.79/share) to close at $146.01 following a second correction notice for Omnipod® 5, Omnipod Dash®, and Omnipod® Eros Pods due to insulin under-delivery risks.

Who is eligible to participate in the Insulet Corporation investor lawsuit?

Investors who purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities on the NASDAQ exchange between February 21, 2025 and May 26, 2026, inclusive (the Class Period), may be eligible to participate. To verify eligibility, investors should review their brokerage records and trade confirmations to ensure their transaction dates fall within this window.

What is the lead plaintiff deadline for the Insulet (PODD) class action?

The deadline for investors to move the court for appointment as lead plaintiff in the Insulet securities litigation is August 31, 2026. The lead plaintiff is typically the investor or institutional group with the largest financial interest in the relief sought who steps forward to oversee the litigation strategy on behalf of the class.

Do I need to become a lead plaintiff to receive a recovery from the Insulet lawsuit?

No. You are not required to serve as a lead plaintiff or take any active legal action to remain an absent class member and participate in a potential future recovery. However, reviewing your trading history with a securities firm before the August 31, 2026 deadline helps ensure your documentation is preserved and your rights are fully protected.

Insulet Corporation - Faruqi & Faruqi LLP

Insulet Corporation

Join Action

Case Details

Ticker PODD

Class Period 02/21/2025 - 05/26/2026

Lead Plaintiff Deadline 08/31/2026

Days Left to Seek Lead Plaintiff

If you are an Insulent Corporation investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Insulet To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Insulet between February 21, 2025 and May 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) and reminds investors of the August 31,2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Insulet’s manufacturing controls and procedures were defective; (ii) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Lead Plaintiff Deadline: August 31, 2026

Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action

Insulet Corporation

Monetary Losses ($) *

Website URL

First Name *

Last Name *

Telephone *

Email *

Street Address

City

State

Zip Code

Purchases

1	Purchases Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date
1	Purchases Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date

Add Row

Sales

1	Sales Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date
1	Sales Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date

Add Row

Upload your trades here:

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Select File

Does not establish an attorney-client relationship *

By clicking this box, I acknowledge that this form is not intended to and does not establish an attorney-client relationship between myself and Faruqi & Faruqi LLP, and that the submission or receipt of information via this form, e-mail or telephone does not create an attorney-client relationship.

Case

Users to notify